sur OXURION (EBR:OXUR)
Oxurion Approves Agenda at Annual Shareholders' Meeting
On June 1, 2026, Oxurion NV held its annual shareholders' meeting in Leuven, Belgium. The biopharmaceutical company announced that all items on the meeting's agenda were approved by the shareholders. The details and documents related to the meeting are accessible on Oxurion's official website.
Oxurion focuses on acquiring majority stakes in promising European pharmaceutical subcontractors. Its goal is to form an integrated group serving healthcare entities. The company's headquarters are located in Leuven.
Oxurion acknowledges the risks and uncertainties related to forward-looking statements mentioned in the release. Therefore, no assurance is given on their materialization. The press release is not an offer for sales or purchase of securities.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION